Role of reactive oxygen species in pathogenesis of radiocontrast-induced nephropathy

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Pisani, Antonio ^a   Riccio, Eleonora ^a   Andreucci, Michele ^b   Faga, Teresa ^b   Ashour, Michael ^b   Di Nuzzi, Antonella ^a   Mancini, Aldo ^c   Sabbatini, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; REACTIVE OXYGEN METABOLITE; RADIOACTIVE IODINE; SCAVENGER;

CONTRAST INDUCED NEPHROPATHY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM INJURY; HUMAN; HYPOXIA; KIDNEY PARENCHYMA; KIDNEY TUBULE ABSORPTION; META ANALYSIS (TOPIC); NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ACUTE KIDNEY FAILURE; CELL HYPOXIA; IATROGENIC DISEASE; METABOLISM; RADIATION EXPOSURE;

ACUTE KIDNEY INJURY; CELL HYPOXIA; CONTRAST MEDIA; FREE RADICAL SCAVENGERS; HUMANS; IATROGENIC DISEASE; IODINE RADIOISOTOPES; REACTIVE OXYGEN SPECIES;

EID: 84897919031     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/868321     Document Type: Review

References (63)

1. Nash K., Hafeez A., Hou S., Hospital-acquired renal insufficiency. American Journal of Kidney Diseases 2002 39 5 930 936 2-s2.0-0036242067 10.1053/ajkd.2002.32766 (Pubitemid 34454211)
2. Heyman S. N., Rosen S., Khamaisi M., Idée J.-M., Rosenberger C., Reactive oxygen species and the pathogenesis of radiocontrast-induced nephropathy. Investigative Radiology 2010 45 4 188 195 2-s2.0-77949867992 10.1097/RLI.0b013e3181d2eed8
3. Kelly A. M., Dwamena B., Cronin P., Bernstein S. J., Carlos R. C., Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy. Annals of Internal Medicine 2008 148 4 284 294 2-s2.0-40049091486 (Pubitemid 351665489)
4. McCullough P. A., Contrast-induced acute kidney injury. Journal of the American College of Cardiology 2008 51 15 1419 1428 2-s2.0-41549152928 10.1016/j.jacc.2007.12.035 (Pubitemid 351471786)
5. Rihal C. S., Textor S. C., Grill D. E., Berger P. B., Ting H. H., Best P. J., Singh M., Bell M. R., Barsness G. W., Mathew V., Garratt K. N., Holmes D. R. Jr., Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002 105 19 2259 2264 2-s2.0-0037076345 10.1161/01.CIR.0000016043.87291.33 (Pubitemid 34535335)
6. Wong P. C. Y., Li Z., Guo J., Zhang A., Pathophysiology of contrast-induced nephropathy. International Journal of Cardiology 2012 158 186 192
7. Mimic-Oka J., Simic T., Djukanovic L., Reljic Z., Davicevic Z., Alteration in plasma antioxidant capacity in various degrees of chronic renal failure. Clinical Nephrology 1999 51 4 233 241 2-s2.0-0032950441 (Pubitemid 29196887)
8. Martín-Mateo M. C., Sánchez-Portugal M., Iglesias S., de Paula A., Bustamante J., Oxidative stress in chronic renal failure. Renal Failure 1999 21 2 155 167 2-s2.0-2542508765 (Pubitemid 29143816)
9. Okamura D. M., Pennathur S., Pasichnyk K., López-Guisa J. M., Collins S., Febbraio M., Heinecke J., Eddy A. A., CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. Journal of the American Society of Nephrology 2009 20 3 495 505 2-s2.0-62149136977 10.1681/ASN. 2008010009
10. Mehran R., Nikolsky E., Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney International 2006 69 100 S11 S15 2-s2.0-33646159540 10.1038/sj.ki.5000368
11. Lasser E. C., Lyon S. G., Berry C. C., Reports on contrast media reactions: analysis of data from reports to the U.S. Food and Drug Administration. Radiology 1997 203 3 605 610 2-s2.0-0031000514 (Pubitemid 27227401)
12. Fiaccadori E., Maggiore U., Rotelli C., Giacosa R., Lombard M., Sagripanti S., Buratti S., Ardissino D., Cabassi A., Plasma and urinary free 3-nitrotyrosine following cardiac angiography procedures with non-ionic radiocontrast media. Nephrology Dialysis Transplantation 2004 19 4 865 869 2-s2.0-1842418627 10.1093/ndt/gfh039 (Pubitemid 38455657)
13. Liss P., Nygren A., Erikson U., Ulfendahl H. R., Injection of low and iso-osmolar contrast medium decreases oxygen tension in the renal medulla. Kidney International 1998 53 3 698 702 2-s2.0-0031915941 10.1046/j.1523-1755. 1998.00811.x (Pubitemid 28124285)
14. Rosenberger C., Rosen S., Heyman S. N., Renal parenchymal oxygenation and hypoxia adaptation in acute kidney injury. Clinical and Experimental Pharmacology and Physiology 2006 33 10 980 988 2-s2.0-33748913696 10.1111/j.1440-1681.2006.04472.x (Pubitemid 44427322)
15. Bakris G. L., Lass N., Gaber A. O., Jones J. D., Burnett J. C. Jr., Radiocontrast medium-induced declines in renal function: a role for oxygen free radicals. American Journal of Physiology 1990 258 1 F115 F120 2-s2.0-0025019379 (Pubitemid 20063077)
16. Toprak O., Cirit M., Tanrisev M., Yazici C., Canoz O., Sipahioglu M., Uzum A., Ersoy R., Sozmen E. Y., Preventive effect of nebivolol on contrast-induced nephropathy in rats. Nephrology Dialysis Transplantation 2008 23 3 853 859 2-s2.0-42449136651 10.1093/ndt/gfm691 (Pubitemid 351767560)
17. Çetin M., Devrim E., Serin Kiliçolu S., Ergüder I. B., Namuslu M., Çetin R., Durak I., Ionic high-osmolar contrast medium causes oxidant stress in kidney tissue: partial protective role of ascorbic acid. Renal Failure 2008 30 5 567 572 2-s2.0-45749093357 10.1080/ 08860220802064739 (Pubitemid 351874062)
18. Goodman A. I., Olszanecki R., Yang L. M., Quan S., Li M., Omura S., Stec D. E., Abraham N. G., Heme oxygenase-1 protects against radiocontrast-induced acute kidney injury by regulating anti-apoptotic proteins. Kidney International 2007 72 8 945 953 2-s2.0-34948892667 10.1038/sj.ki.5002447 (Pubitemid 47530569)
19. Efrati S., Dishy V., Averbukh M., Blatt A., Krakover R., Weisgarten J., Morrow J. D., Stein M. C., Golik A., The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney International 2003 64 6 2182 2187 2-s2.0-0344945450 10.1046/j.1523-1755.2003. 00322.x (Pubitemid 37449553)
20. Drager L. F., Andrade L., Barros de Toledo J. F., Laurindo F. R. M., Machado César L. A., Seguro A. C., Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrology Dialysis Transplantation 2004 19 7 1803 1807 2-s2.0-3242724889 10.1093/ndt/gfh261 (Pubitemid 38961391)
21. Katholi R. E., Woods W. T. Jr., Taylor G. J., Deitrick C. L., Womack K. A., Katholi C. R., McCann W. P., Oxygen free radicals and contrast nephropathy. American Journal of Kidney Diseases 1998 32 1 64 71 2-s2.0-0031835577 (Pubitemid 28311873)
22. Garofalo A. S., Borges F. T., Dalboni M. A., Santos O. F. P. D., Reactive oxygen species independent cytotoxicity induced by radiocontrast agents in tubular cells (LLC-PK1 and MDCK). Renal Failure 2007 29 2 121 131 2-s2.0-33847215772 10.1080/08860220601095892
23. Romano G., Briguori C., Quintavalle C., Zanca C., Rivera N. V., Colombo A., Condorelli G., Contrast agents and renal cell apoptosis. European Heart Journal 2008 29 20 2569 2576 2-s2.0-54149089710 10.1093/eurheartj/ehn197
24. Quintavalle C., Brenca M., De Micco F., Fiore D., Romano S., Romano M. F., Apone F., Bianco A., Zabatta M. A., Troncone G., Briguori C., Condorelli G., In vivo and in vitro assessment of pathways involved in contrast media-induced renal cells apoptosis. Cell Death and Disease 2011 2 5, article e155 2-s2.0-79960016113 10.1038/cddis.2011.38
25. Sabbatini M., Santillo M., Pisani A., Paternò R., Uccello F., Serù R., Matrone G., Spagnuolo G., Andreucci M., Serio V., Esposito P., Cianciaruso B., Fuiano G., Avvedimento E. V., Inhibition of Ras/ERK1/2 signaling protects against postischemic renal injury. American Journal of Physiology 2006 290 6 F1408 F1415 2-s2.0-33744781526 10.1152/ajprenal.00304.2005 (Pubitemid 43830766)
26. Andreucci M., Fuiano G., Presta P., Esposito P., Faga T., Bisesti V., Procino A., Altieri V., Tozzo C., Memoli B., Michael A., Radiocontrast media cause dephosphorylation of Akt and downstream signaling targets in human renal proximal tubular cells. Biochemical Pharmacology 2006 72 10 1334 1342 2-s2.0-33750201137 10.1016/j.bcp.2006.08.008 (Pubitemid 44604287)
27. Andreucci M., Faga T., Russo D., Bertucci B., Tamburrini O., Pisani A., Sabbatini M., Fuiano G., Michael A., Differential activation of signaling pathways by low-osmolar and iso-osmolar radiocontrast agents in human renal proximal tubular cells. Journal of Cellular Biochemistry 2013 115 2 281 289 10.1002/jcb.24662
28. Andreucci M., Lucisano G., Faga T., Bertucci B., Tamburrini O., Pisani A., Sabbatini M., Salzano S., Vitale M., Fuiano G., Michael A., Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells. Toxicological Sciences 2011 119 2 408 416 2-s2.0-78751688950 10.1093/toxsci/kfq332
29. Tepel M., Van Der Giet M., Schwarzfeld C., Laufer U., Liermann D., Zidek W., Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. The New England Journal of Medicine 2000 343 3 180 184 2-s2.0-0034691822 10.1056/NEJM200007203430304 (Pubitemid 30489215)
30. Birck R., Krzossok S., Markowetz F., Schnülle P., Van Der Woude F. J., Braun C., Acetylcysteine for prevention of contrast nephropathy: meta-analysis. The Lancet 2003 362 9384 598 603 2-s2.0-0042466568 10.1016/S0140-6736(03)14189-X (Pubitemid 37013299)
31. Alonso A., Lau J., Jaber B. L., Weintraub A., Sarnak M. J., Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials. American Journal of Kidney Diseases 2004 43 1 1 9 2-s2.0-0347990333 10.1053/j.ajkd.2003.09.009 (Pubitemid 38049429)
32. Zagler A., Azadpour M., Mercado C., Hennekens C. H., N-Acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. American Heart Journal 2006 151 1 140 145 2-s2.0-29144523846 10.1016/j.ahj.2005.01.055 (Pubitemid 41815344)
33. Nallamothu B. K., Shojania K. G., Saint S., Hofer T. P., Humes H. D., Moscucci M., Bates E. R., Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis. American Journal of Medicine 2004 117 12 938 947 2-s2.0-11344275793 10.1016/j.amjmed.2004.06.046 (Pubitemid 40075562)
34. Pannu N., Manns B., Lee H., Tonelli M., Systematic review of the impact of N-acetylcysteine on contrast nephropathy. Kidney International 2004 65 4 1366 1374 2-s2.0-1642545171 10.1111/j.1523-1755.2004.00516.x (Pubitemid 38406975)
35. Gonzales D. A., Norsworthy K. J., Kern S. J., Banks S., Sieving P. C., Star R. A., Natanson C., Danner R. L., A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity. BMC Medicine 2007 5, article 32 2-s2.0-38349106545 10.1186/1741-7015-5-32
36. Kshirsagar A. V., Poole C., Mottl A., Shoham D., Franceschini N., Tudor G., Agrawal M., Denu-Ciocca C., Ohman E. M., Finn W. F., N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. Journal of the American Society of Nephrology 2004 15 3 761 769 2-s2.0-10744229574 10.1097/01.ASN.0000116241.47678.49 (Pubitemid 38294807)
37. Briguori C., Airoldi F., D'Andrea D., Bonizzoni E., Morici N., Focaccio A., Michev I., Montorfano M., Carlino M., Cosgrave J., Ricciardelli B., Colombo A., Renal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategies. Circulation 2007 115 10 1211 1217 2-s2.0-33947716173 10.1161/CIRCULATIONAHA.106.687152 (Pubitemid 46594764)
38. Briguori C., Colombo A., Violante A., Balestrieri P., Manganelli F., Elia P. P., Golia B., Lepore S., Riviezzo G., Scarpato P., Focaccio A., Librera M., Bonizzoni E., Ricciardelli B., Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. European Heart Journal 2004 25 3 206 211 2-s2.0-10744233453 10.1016/j.ehj.2003.11.016 (Pubitemid 38235156)
39. Marenzi G., Assanelli E., Marana I., Lauri G., Campodonico J., Grazi M., De Metrio M., Galli S., Fabbiocchi F., Montorsi P., Veglia F., Bartorelli A. L., N-acetylcysteine and contrast-induced nephropathy in primary angioplasty. The New England Journal of Medicine 2006 354 26 2773 2782 2-s2.0-33745641529 10.1056/NEJMoa054209 (Pubitemid 43974195)
40. Efrati S., Berman S., Ilgiyeav I., Siman-Tov Y., Averbukh Z., Weissgarten J., Differential effects of N-acetylcysteine, theophylline or bicarbonate on contrast-induced rat renal vasoconstriction. American Journal of Nephrology 2009 29 3 181 191 2-s2.0-51049083848 10.1159/000154471
41. Merten G. J., Burgess W. P., Gray L. V., Holleman J. H., Roush T. S., Kowalchuk G. J., Bersin R. M., Van Moore A., Simonton C. A. III, Rittase R. A., Norton H. J., Kennedy T. P., Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. Journal of the American Medical Association 2004 291 19 2328 2334 2-s2.0-2442590642 10.1001/jama.291.19. 2328 (Pubitemid 38656299)
42. Tamura A., Goto Y., Miyamoto K., Naono S., Kawano Y., Kotoku M., Watanabe T., Kadota J., Efficacy of single-bolus administration of sodium bicarbonate to prevent contrast-induced nephropathy in patients with mild renal insufficiency undergoing an elective coronary procedure. American Journal of Cardiology 2009 104 7 921 925 2-s2.0-70249117867 10.1016/j.amjcard.2009.05.034
43. Masuda M., Yamada T., Mine T., Morita T., Tamaki S., Tsukamoto Y., Okuda K., Iwasaki Y., Hori M., Fukunami M., Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure. American Journal of Cardiology 2007 100 5 781 786 2-s2.0-34547947413 10.1016/j.amjcard.2007.03.098 (Pubitemid 47268267)
44. Recio-Mayoral A., Chaparro M., Prado B., Cózar R., Méndez I., Banerjee D., Kaski J. C., Cubero J., Cruz J. M., The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study. Journal of the American College of Cardiology 2007 49 12 1283 1288 2-s2.0-33947512067 10.1016/j.jacc.2006.11.034 (Pubitemid 46467227)
45. Ozcan E. E., Guneri S., Akdeniz B., Akyildiz I. Z., Senaslan O., Baris N., Aslan O., Badak O., Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. American Heart Journal 2007 154 3 539 544 2-s2.0-34547944556 10.1016/j.ahj.2007.05.012 (Pubitemid 47268251)
46. Pakfetrat M., Nikoo M. H., Malekmakan L., Tabandeh M., Roozbeh J., Nasab M. H., Ostovan M. A., Salari S., Kafi M., Vaziri N. M., Adl F., Hosseini M., Khajehdehi P., A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial. International Urology and Nephrology 2009 41 3 629 634 2-s2.0-67649989950 10.1007/s11255-008- 9520-y
47. Brar S. S., Shen A. Y.-J., Jorgensen M. B., Kotlewski A., Aharonian V. J., Desai N., Ree M., Shah A. I., Burchette R. J., Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial. Journal of the American Medical Association 2008 300 9 1038 1046 2-s2.0-50949083026 10.1001/jama.300.9. 1038
48. Schmidt P., Pang D., Nykamp D., Knowlton G., Jia H., N-acetylcysteine and sodium bicarbonate versus N-acetylcysteine and standard hydration for the prevention of radiocontrast-induced nephropathy following coronary angiography. Annals of Pharmacotherapy 2007 41 1 46 50 2-s2.0-33846437080 10.1345/aph.1H354 (Pubitemid 46145956)
49. Adolph E., Holdt-Lehmann B., Chatterjee T., Paschka S., Prott A., Schneider H., Koerber T., Ince H., Steiner M., Schuff-Werner P., Nienaber C. A., Renal insufficiency following radiocontrast exposure trial (REINFORCE): a randomized comparison of sodium bicarbonate versus sodium chloride hydration for the prevention of contrast-induced nephropathy. Coronary Artery Disease 2008 19 6 413 419 2-s2.0-56649093581 10.1097/MCA.0b013e3283021ac6
50. Maioli M., Toso A., Leoncini M., Gallopin M., Tedeschi D., Micheletti C., Bellandi F., Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Journal of the American College of Cardiology 2008 52 8 599 604 2-s2.0-48849097250 10.1016/j.jacc.2008.05.026
51. Hogan S. E., L'Allier P., Chetcuti S., Grossman P. M., Nallamothu B. K., Duvernoy C., Bates E., Moscucci M., Gurm H. S., Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis. American Heart Journal 2008 156 3 414 421 2-s2.0-49949098247 10.1016/j.ahj.2008.05.014
52. Navaneethan S. D., Singh S., Appasamy S., Wing R. E., Sehgal A. R., Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis. American Journal of Kidney Diseases 2009 53 4 617 627 2-s2.0-62749137422 10.1053/j.ajkd.2008.08.033
53. Meier P., Ko D. T., Tamura A., Tamhane U., Gurm H. S., Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis. BMC Medicine 2009 7, article 23 2-s2.0-66149163816 10.1186/1741-7015-7-23
54. Ho K. M., Morgan D. J., Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: a meta-analysis. Anaesthesia and Intensive Care 2008 36 5 646 653 2-s2.0-51849106506
55. Solomon R.,. BOSS trials results presentation TCT Meeting, October 2013
56. Li G., Yin L., Liu T., Zheng X., Xu G., Xu Y., Yuan R., Che J., Liu H., Zhou L., Chen X., He M., Li Y., Wu L., Liu E., Role of probucol in preventing contrast-induced acute kidney injury after coronary interventional procedure. American Journal of Cardiology 2009 103 4 512 514 2-s2.0-59049104321 10.1016/j.amjcard.2008.10.009
57. Jo S.-H., Koo B.-K., Park J.-S., Kang H.-J., Kim Y.-J., Kim H.-L., Chae I.-H., Choi D.-J., Sohn D.-W., Oh B.-H., Park Y.-B., Choi Y.-S., Kim H.-S., N-acetylcysteine versus AScorbic acid for preventing contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial. American Heart Journal 2009 157 3 576 583 2-s2.0-60949106571 10.1016/j.ahj.2008.11.010
58. Spargias K., Alexopoulos E., Kyrzopoulos S., Iacovis P., Greenwood D. C., Manginas A., Voudris V., Pavlides G., Buller C. E., Kremastinos D., Cokkinos D. V., Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 2004 110 18 2837 2842 2-s2.0-8144224968 10.1161/01.CIR.0000146396.19081.73 (Pubitemid 39473606)
59. Boscheri A., Weinbrenner C., Botzek B., Reynen K., Kuhlisch E., Strasser R. H., Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. Clinical Nephrology 2007 68 5 279 286 2-s2.0-35748975978 (Pubitemid 350047760)
60. Hellman R. N., Novikov M., Campos S., Acetazolamide is renoprotective in a rat model of high dose contrast media induced renal failure. Journal of the American Society of Nephrology 2004 15 717A
61. Assadi F., Acetazolamide for prevention of contrast-induced nephropathy: a new use for an old drug. Pediatric Cardiology 2006 27 2 238 242 2-s2.0-33645120986 10.1007/s00246-005-1132-z
62. Quintavalle C., Fiore D., De Micco F., Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 2012 126 25 3008 3016
63. Pisani A., Sabbatini M., Riccio E., Effect of a recombinant manganese superoxide dismutase on prevention of contrast-induced acute kidney injury. Clinical and Experimental Nephrology 2013 10.1007/s10157-013-0828-2